Skip to main content

Brexafemme Side Effects

Generic name: ibrexafungerp

Medically reviewed by Drugs.com. Last updated on Oct 5, 2022.

Note: This document contains side effect information about ibrexafungerp. Some dosage forms listed on this page may not apply to the brand name Brexafemme.

Applies to ibrexafungerp: oral tablet.

Serious side effects of Brexafemme

Along with its needed effects, ibrexafungerp (the active ingredient contained in Brexafemme) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking ibrexafungerp:

Less common

  • Difficulty in breathing or swallowing
  • fast heartbeat
  • lower stomach pain or cramps
  • skin itching, rash, or redness
  • swelling of the face, throat, or tongue
  • vaginal bleeding

Other side effects of Brexafemme

Some side effects of ibrexafungerp may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to ibrexafungerp: oral tablet.

Gastrointestinal

Very common (10% or more): Diarrhea (16.7%), nausea (11.9%), abdominal pain (11.4%; included abdominal pain, upper abdominal pain, lower abdominal pain, abdominal discomfort)

Common (1% to 10%): Vomiting

Frequency not reported: Flatulence[Ref]

Nervous system

Common (1% to 10%): Dizziness (included dizziness, postural dizziness)[Ref]

Genitourinary

Frequency not reported: Dysmenorrhea, vaginal bleeding[Ref]

Musculoskeletal

Frequency not reported: Back pain[Ref]

Hepatic

Frequency not reported: Elevated transaminases[Ref]

Dermatologic

Frequency not reported: Rash[Ref]

Hypersensitivity

Frequency not reported: Hypersensitivity reaction[Ref]

References

1. "Product Information. Brexafemme (ibrexafungerp)." SCA Pharmaceuticals (2021):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.